Complex Attention-Deficit Hyperactivity Disorder in a 4-Year-Old With Repaired Critical Congenital Heart Disease and Autism Spectrum Disorder.

This is a single case report, so the outcomes cannot be generalized to other children with similar conditions. The child received multiple interventions simultaneously (medications, ABA, parent training, school support), making it impossible to determine which specific component led to the improvements in behavior and communication. Outcomes are largely based on parental report and clinical observation rather than standardized, blinded outcome measures. The cardiac safety monitoring was specific to this child's physiology; other children with different cardiac histories may react differently to the same medications.

One author, K.E. Wallis, has served as a consultant for Thomas Jefferson University and Healthy Steps and received honoraria. No funding source for the study itself is explicitly stated in the text provided, though the authors include clinicians from pediatric and cardiology departments.

Do not conclude that clonidine or amphetamine-dextroamphetamine are effective treatments for ADHD in all children with congenital heart disease. This is a single case where the combination of multiple behavioral supports and sequential medication trials led to improvement, and the specific cardiac safety profile (asymptomatic bradycardia) was managed with intensive monitoring that may not be applicable to every patient.